Influence of environmental factors on the onset and course of inflammatory bowel disease

World Journal of Gastroenterology : WJG
Amit Kumar Dutta, Ashok Chacko

Abstract

Numerous environmental factors have been linked with inflammatory bowel disease. These include smoking, diet, hygiene, drugs, geographical and psychosocial factors. These factors may either increase the risk of or protect against developing this condition and can also affect the course of illness in a positive or negative manner. A number of studies have examined the influence of environmental factors on inflammatory bowel diseases as a whole as well as on ulcerative colitis and Crohn's disease separately. As there are differences in the pathogenesis of ulcerative colitis and Crohn's disease, the effect of environmental factors on their onset and course is not always similar. Some factors have shown a consistent association, while reports on others have been conflicting. In this article we discuss the current evidence on the roles of these factors on inflammatory bowel disease, both as causative/protective agents and as modifiers of disease course.

References

Nov 1, 1988·Scandinavian Journal of Gastroenterology·E J BoykoT S Inui
Apr 29, 1995·Lancet·N P ThompsonA J Wakefield
May 1, 1994·Gastroenterology·P RutgeertsG Vantrappen
Mar 1, 1996·European Journal of Gastroenterology & Hepatology·B D Breuer-KatschinskiH Goebell
Nov 26, 1999·Alimentary Pharmacology & Therapeutics·J CosnesJ Gendre
May 16, 2000·The American Journal of Gastroenterology·S LevensteinA Marcheggiano
Aug 19, 2000·The American Journal of Gastroenterology·J B FelderG Gleim
Jan 11, 2001·The American Journal of Gastroenterology·D L MorrisA J Wakefield
Mar 15, 2001·European Journal of Gastroenterology & Hepatology·N Mahmud, D G Weir
Mar 15, 2001·The New England Journal of Medicine·R E AnderssonA Ekbom
Mar 27, 2001·Gastroenterology·J CosnesJ P Gendre
Jan 16, 2004·Gut·T CardJ G Wheeler
Jan 18, 2006·Epidemiology and Infection·P H JonesK L Morgan
Feb 14, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ken TakeuchiIngvar Bjarnason
Feb 14, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·William J SandbornBradley J Bloom
Sep 21, 2006·Clinical Practice and Epidemiology in Mental Health : CP & EMH·Antonina A Mikocka-WalusGerald J Holtmann
Nov 15, 2006·The American Journal of Gastroenterology·Eric LereboursJacques Benichou
Nov 24, 2006·Mayo Clinic Proceedings·Suhal S MahidSusan Galandiuk
Jun 9, 2007·The American Journal of Gastroenterology·Ole HöieUNKNOWN European Collaborative Study Group of Inflammatory Bowel Disease (EC-IBD)
Jul 10, 2007·The American Journal of Gastroenterology·Devendra K AmreErnest G Seidman
Sep 5, 2007·Alimentary Pharmacology & Therapeutics·P DziechciarzH Szajewska
Dec 20, 2007·Inflammatory Bowel Diseases·Savio D'SouzaDevendra K Amre
Jan 12, 2008·World Journal of Gastroenterology : WJG·Natasha-A KoloskiGraham Radford-Smith
Aug 6, 2008·Inflammatory Bowel Diseases·Joel V Weinstock, David E Elliott
Aug 8, 2008·The American Journal of Gastroenterology·Julie A CornishParis P Tekkis
Sep 9, 2008·The American Journal of Gastroenterology·Gilaad G KaplanJoshua Korzenik
Oct 11, 2008·The American Journal of Gastroenterology·Deborah T JonesJames D Lewis
Dec 11, 2008·Inflammatory Bowel Diseases·Philippe SeksikJacques Cosnes
Jan 29, 2009·The American Journal of Gastroenterology·Gary R LichtensteinUNKNOWN Practice Parameters Committee of American College of Gastroenterology
May 23, 2009·Inflammatory Bowel Diseases·Christine A Chapman-KiddellGraham L Radford-Smith
May 26, 2009·The Journal of Pediatrics·Andrew R BarclayDavid C Wilson
Jan 16, 2010·Journal of Gastroenterology and Hepatology·Richard B GearryMurray L Barclay
Apr 8, 2010·The American Journal of Gastroenterology·Charles N BernsteinMary Cheang
Jul 1, 2010·The American Journal of Gastroenterology·Gilaad G KaplanPaul J Villeneuve

❮ Previous
Next ❯

Citations

Dec 23, 2016·Médecine sciences : M/S·Oumaira RahmouniChristel Neut
Sep 19, 2018·Innate Immunity·Julien Rs DandrieuxCaroline S Mansfield
Jul 17, 2019·Intestinal research·Yong Eun ParkJae Hee Cheon
Aug 4, 2020·World Journal of Gastroenterology : WJG·Valéria Cristina Loureiro SalgadoCyrla Zaltman
May 28, 2017·Digestive Diseases and Sciences·Laura TassonRenzo Zanotti
Nov 20, 2020·International Journal of Environmental Research and Public Health·Dubravka HolikAleksandar Včev
Apr 24, 2021·Medicinal Research Reviews·Firdos A KhanFaheem H Pottoo
Apr 24, 2020·Environmental Pollution·Quentin M TenailleauFlorent Occelli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.